Trial Details

COMPLETED
Basic Information
Clinical ID c4266
Identifier NCT00774007
Trial Title A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome
Interventions DRUG: mesalazine|DRUG: placebo
Participant Information
Sponsor SOFAR S.p.A.
City Bologna
Country/Region Italy
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2|PHASE3
Time Information
Start Date 2004-09
Primary Completion Date 2005-11
Completion Date 2005-11